| Not Yet Recruiting | Zanubrutinib, Rituximab, and Lenalidomide in the First-Line Treatment of Marginal Zone Lymphoma Marginal Zone Lymphoma(MZL) | N/A | 2026-01-01 |
| Not Yet Recruiting | ZSDT for the Treatment of R/R Mantle Cell Lymphoma After BTK Inhibitor Failure: a Multi-center Prospective Cli Mantle Cell Lymphoma (MCL) | Phase 4 | 2025-12-31 |
| Not Yet Recruiting | Relmacabtagene Autoleucel Combined With Autologous Hematopoietic Stem Cell Transplantation, Orelabrutinib, and Primary Central Nervous System Lymphoma (PCNSL) | N/A | 2025-10-07 |
| Not Yet Recruiting | CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation CD7+ Lymphoma, T Cell Lymphoma | Phase 1 / Phase 2 | 2025-09-01 |
| Not Yet Recruiting | Glofitamab for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma B Cell Lymphoma (BCL) | Phase 4 | 2025-05-30 |
| Recruiting | Axicabtagene Ciloleucel for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma Lymphoma, B-Cell | Phase 4 | 2024-09-30 |
| Active Not Recruiting | A Multi-center Clinical Study of Zanubrutinib in Combination With First-line Chemoimmunotherapy in Patients Wi Follicular Lymphoma | — | 2024-05-01 |
| Unknown | Effect of Educational Program on Parental Stress of Parents of Children With CHD Congenital Heart Defect | N/A | 2024-01-30 |
| Active Not Recruiting | Clinical Study of CEP+Dasatinib + Azacytidine in First-line Treatment of. Angioimmunoblastoma Foresight Angioimmunoblastic T-cell Lymphoma (AITL) | Phase 4 | 2023-10-21 |
| Unknown | Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited, r/r B-NHL | Phase 1 | 2022-09-02 |
| Completed | Improving Wellbeing in Older Adults: The Impact of an Active Aging Education Program in Pakistan Aging Well, Well Aging, Quality of Life | N/A | 2022-08-15 |
| Recruiting | A Clinical Study of Hanlikang and BTK Inhibitors in the Treatment of Newly Diagnosed Mantle Cell Lymphoma Newly Diagnosed Mantle Cell Lymphoma | — | 2022-08-12 |
| Completed | Dyadic Interventions to Boost Quality of Life Among Stroke Survivors and Care Partners in Pakistan. Chronic Stroke | N/A | 2021-10-01 |
| Completed | Impact of Baduanjin Exercise Combined With Rational Emotive Behavior Therapy on Sleep and Mood in Patients Wit Stroke | N/A | 2021-06-20 |
| Unknown | A Prospective Clinical Study of Ruxolitinib and Etoposide Combined With DDGP Regimen (RUE-DDGP) in Induction T Hemophagocytic Syndrome, T/NK-Cell Lymphoma | Phase 4 | 2021-05-30 |
| Unknown | Treatment of Newly Diagnosed Peripheral T-cell Lymphoma Newly Diagnosed Peripheral T-cell Lymphoma | Phase 4 | 2018-09-01 |
| Completed | Apatinib for Relapsed and Refractory Diffuse Large B Cell Lymphoma Relapsed and Refractory, Diffuse Large B Cell Lymphoma | Phase 4 | 2017-01-01 |
| Completed | Effectiveness and Economic Evaluation of Glass Ionomer Material Using as Dental Sealant Glass Ionomer Cement, Cost-effectiveness, Pit and Fissure Caries (Disorder) | Phase 4 | 2016-01-01 |
| Completed | Effect of Erythropoietin on Neurodevelopmental Outcomes in Very Preterm Infants With Intraventricular Hemorrha Premature Infants | Phase 2 | 2014-07-01 |
| Completed | Erythropoietin Protects Very Preterm Infants Against Necrotizing Enterocolitis Premature Infant | Phase 2 | 2014-01-01 |
| Unknown | Prognosis Factors in Patients With Primary Central Nervous System Lymphoma PCNSL, Survival Analysis | — | 2013-09-01 |
| Completed | Recanalization and Stenting for Non-acute Veterbrobasilar Artery Occlusion Stroke | N/A | 2013-04-01 |
| Unknown | Radiotherapy vs Observation for CRPC Hormone Refractory Prostate Cancer | — | 2012-05-01 |
| Completed | Neurological Outcome After Erythropoietin Treatment for Neonatal Encephalopathy Hypoxic-Ischemic Encephalopathy | Phase 1 / Phase 2 | 2003-08-01 |
| Completed | Management of Prostate Cancer in Central China Prostate Cancer | — | 2003-01-01 |
| Completed | Systemic Hypothermia Improves Outcome of Hypoxic-Ischemic Encephalopathy Hypoxic-Ischemic Encephalopathy | Phase 1 / Phase 2 | 2002-07-01 |